Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
semaglutide
Research
Biolexis enters small molecule into oral GLP-1 horse race
Biolexis Therapeutics’ small molecule BLX-7006 reduced the weight of obese mice by 15% over a 28-day span.
Darren Incorvaia
Sep 13, 2024 12:24pm
Terns' ex-MASH drug cuts fat, not muscle in GLP-1 combo in mice
Jun 25, 2024 8:51am
Fractyl's GLP-1 gene therapy makes weight loss last in mice
Jun 24, 2024 11:11am
A look at the R&D landscape in obesity, led by GLP-1s
Mar 19, 2024 8:00am
Another win for Novo in obesity as early oral med beats Wegovy
Mar 7, 2024 9:27am
Novo Nordisk advances obesity pill as R&D spend skyrockets 35%
Jan 31, 2024 9:44am